Background and Purpose: The purpose of this study was to evaluate the prevalence of coronary artery disease and coronary events during follow-up in patients with asymptomatic carotid stenosis, transient ischemic attacks, or small strokes.
T1 defects. In 26 patients with a history of coronary artery disease, 15 (58%) had reversible and/or fixed defects (p=0.054 compared with patients with no history). A history of peripheral vascular disease was the only risk factor significantly associated with an abnormal 2O 'TI test (p=0.032). Coronary artery stenosis of greater than 50% was identified in one or more vessels in 14 of 15 patients undergoing coronary arteriography. Over a mean follow-up period of 311 days, four patients (7%) developed new onset of angina. There were four coronary events among 14 patients (29%) with both a reversible area on the 2O 'TI and abnormal coronary arteriography. In comparison, there were only four coronary events among 46 patients (9%) without reversible defects on the 201 Tl studies (p=0.055). Conclusions: Our study demonstrates that one third of patients with no history of coronary artery disease had an abnormal 201 TI test and that nearly one half of patients with either symptomatic or asymptomatic cerebrovascular disease had abnormal C erebrovascular disease and coronary artery disease (CAD) have similar risk factors and often coexist. The association is so strong that after presentation with threatened stroke, patients may be at higher risk for a myocardial infarction than for a stroke. 1 The 5-6% annual mortality rate after transient ischemic attacks (TIAs) is mainly due to myocardial infarction, 23 which is similar to the 4% annual cardiac mortality rate in patients with stable angina pectoris. 4 In patients with asymptomatic carotid bruit, the risk of myocardial infarction is approximately equal to that of stroke. 5 After stroke, the presence of CAD adversely affects survival. 6 In spite of the recognition that CAD and cerebrovascular disease are associated, it is not currently a routine practice to evaluate patients with early cerebrovascular disease for asymptomatic or symptomatic CAD. Thallium-201-dipyridamole scintigraphy has proven to be of value in predicting cardiac risk in patients with peripheral vascular disease before peripheral vascular surgery. T1 scan is an independent predictor of subsequent myocardial infarction or cardiac death and increases the risk of a future cardiac event by more than threefold.
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To assess the prevalence of significant CAD and of coronary events among patients with asymptomatic carotid bruits or stenosis, TIAs, or small strokes, consecutive patients were prospectively evaluated according to our protocol using either 201 Tl-treadmill exercise or with carotid or vertebrobasilar TIAs, or with small, nondisabling strokes were eligible for study using 2O1 T1 scintigraphy and/or coronary arteriography. The protocol was approved by the institutional review boards governing research in human subjects. Patients were excluded from the study if they had contraindications for 2O1 T1 scintigraphy. Women of childbearing potential had serum or urine )3-human chorionic gonadotropin quantification before entry. Patients with presumed or definite cardioembolic cerebral ischemia were excluded.
Risk factors for atherosclerosis and past history of stroke, TIA, angina, myocardial infarction, arrhythmias, carotid endarterectomy, coronary artery bypass grafting, coronary angioplasty, and peripheral vascular surgery were documented. Cardiac history was defined as the presence or history of angina or myocardial infarction, or as electrocardiographic (ECG) changes indicative of a prior myocardial infarction or ischemia. Carotid bruits were detected by carotid artery auscultation. Patients underwent routine blood testing; most had testing of serum cholesterol and triglyceride levels, and some had testing of high density lipoprotein and low density lipoprotein levels when the total cholesterol was elevated. Electrocardiograms were obtained on all patients. Most patients had a chest roentgenogram. Unenhanced computed tomography (CT) and/or magnetic resonance imaging (MRI) of the brain was performed on all patients with TIAs or small strokes. Small strokes were defined as nondisabling deficits associated with a lesion by CT or MRI involving less than half a lobe of the brain.
All patients with carotid bruit underwent carotid duplex scans to determine whether stenosis was present. Patients with a carotid bruit associated with carotid stenosis of less than 50% were excluded. Noninvasive grading of carotid artery stenosis was made by the Doppler velocities and spectral broadening. Cerebral angiography was obtained at the discretion of the attending physician. Percent carotid stenosis by angiography was calculated from the minimal residual lumen (MRL) and the distal lumen (DL) by the equation l-(MRL/DL)xl00. Cerebral angiography, MRI, and CT of the brain were read by a single, blinded investigator.
Screening for the presence of CAD was performed according to the protocols shown in Figures 1 and 2 . T1 tests were performed in patients who, by history, could not perform maximal treadmill exercise testing because of vascular claudication, severe lung disease, or orthopedic problems. Exercise testing was performed using a standard Bruce protocol. Exercise was stopped for the following reasons: fatigue, shortness of breath, attainment of 80% of the maximal predicted heart rate, or ischemic electrocardiographic changes. Dipyridamole testing was performed as previously described. 13 A standard dose of intravenous dipyridamole (0.56 mg/kg given over 4 minutes; Boehinger Ingelheim, Ltd) was administered with an infusion pump. Heart rate, blood pressure, and a 12-lead ECG were recorded initially and every minute until the patient underwent imaging.
One minute before stopping exercise or 5 minutes after the end of the dipyridamole infusion, 
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Early + treadmill, and/or large or multiple reversible defects. T1 imaging (180° acquisition) was performed in patients who weighed less than 240 pounds and in women without marked breast enlargement using a large field of view detector, a 0.25-inchthick crystal, and a low-energy, all-purpose, parallel hole collimator (Siemens Orbiter). The planar images were acquired in the anterior, left anterior oblique, and lateral decubitus projections. Tomographic images were reconstructed using a standard filtered back-projection technique with a low-resolution Henning filter (Medical Data Systems, Ann Arbor, Mich.). If the immediate images were interpreted as normal, the patient did not return for delayed images. Delayed images were obtained approximately 3 hours after the immediate images. For patients imaged using the standard protocol, images were obtained after reinjection of 2O1 T1 at rest on a separate day if only minimal redistribution of 2O1 T1 was seen on the delayed images or if a fixed defect was identified in a patient without a history of myocardial infarction.
FIGURE 1. Diagram of screening process for coronary artery disease in patients with asymptomatic carotid stenosis, transient ischemic attacks (TIAs), or small strokes and a history or electrocardiographic (ECG) evidence of coronary artery disease (CAD
All ECG results were interpreted blindly according to standard criteria 14 by a single cardiologist. The exercise ECG results were interpreted as positive if the ST segment was flat or downsloping and depressed more than 0.1 mv at 80 msec after the J point. Tl uptake was equivalent to background. Twenty segments were scored on the tomographic images, six segments on each of three short axis images, and two apical segments on the vertical long axis. 16 A defect was defined as fixed if no change in 2O1 T1 uptake was noted, including that on the rest study. A reversible defect was defined as an initially abnormal 2O1 T1 uptake (grades 3-4) that became normal (grades 0-1) on the delayed images. A partially reversible defect was defined as an initially abnormal 2O1 T1 uptake (grades 3-4) that partially improved but did not normalize (grades 2-3). Quantitative analysis was available to confirm qualitative evaluation. 17 Patients were asked to undergo coronary arteriography if the 201 Tl study demonstrated clearly abnormal 2O1 T1 images or the patient developed either cardiovascular symptoms or ischemic ECG changes. Coronary angiograms were obtained in multiple projections and interpreted both visually and by quantitative analysis by a single observer. 18 Significant CAD was defined as 50% lumen diameter stenosis or greater by quantitative analysis.
Patients were seen for follow-up by one of the investigators at intervals determined by their clinical situation, which was in general every 3-6 months. Two patients failed to report for visits and were contacted by telephone. Inquiries were made regarding cardiac or cerebral events. Cerebral events were defined as TIA or stroke during the follow-up period. Cardiac events were defined as new-onset angina, new-onset atrial fibrillation, coronary artery bypass grafting, myocardial infarction, or cardiac death. Tl studies had significant CAD by angiography, with two demonstrating "balanced disease" (i.e., comparable, severe stenosis in all three coronary arteries). The other patient had angina with an occluded bypass graft to a second-order artery by angiography. Not all patients with reversible defects on 201 Tl tests had coronary arteriography: one patient declined the test, three had serious, concomitant medical illness that precluded testing, and one received medical therapy without undergoing coronary arteriography at the recommendation of his physician.
The following treatments were administered during the follow-up study period: aspirin, 58 patients; warfarin (Coumadin, Du Pont Pharmaceuticals), two patients; carotid endarterectomy, 13 patients; and nitrates, calcium channel blockers, or /3-blockers, 17 patients. Percutaneous transluminal coronary angioplasty was performed in one patient and coronary artery bypass grafting in two patients as a result of abnormal 2O1 T1 tests and significant CAD.
Patients received follow-up for 61-591 (mean, 311) days. Complications that occurred during follow-up included new onset of angina in four patients (7%); atrial fibrillation in two (3%); TIAs in three (5%); recurrent strokes in two (3%); and death in two (3%), resulting from suicide in one patient and mesenteric thrombosis in a patient with atrial fibrillation.
During follow-up, cardiac events were more common than cerebral events (Table 4 ). There was no difference in the follow-up event rate between those patients with symptomatic or those with asymptomatic cerebrovascular disease. The cerebral event rate was numerically greater in patients with carotid stenosis >50% (/?=NS). Those patients with reversible 201 Tl defects had a numerically greater cardiac event rate (/?=NS). In patients with any abnormality on 201 Tl testing or with normal 2O1 T1 results but with development of cardiac symptoms, coronary angiography showing one or more vessels with >50% stenosis was associated with a higher numeric cardiac event rate than the group with <50% coronary arterial stenosis. Analysis of patients with reversible 2O1 T1 defects and coronary arterial stenosis of >50% showed a 29% cardiac event rate during the Defined as new-onset angina, new-onset atrial fibrillation, coronary artery bypass grafting, myocardial infarction, or cardiac death.
*By either carotid duplex or cerebral angiography; not all patients had the tests.
follow-up period compared with a 9% cardiac event rate among those without a reversible 2O1 T1 defect (p=0.055; Figure 3 ). These patients had a similar cerebral event rate (0% versus ll%,p=NS; Figure 3 ).
Discussion
This study showed that abnormal 2O1 T1 test results had similar prevalence in patients with asymptomatic and those with symptomatic carotid stenosis. CAD was common, even among patients with no cardiac history. In our patients, an abnormal 201 Tl test result was more common with advanced age and symptomatic peripheral vascular disease. Most important, our follow-up data indicated that the combination of a reversible 2O1 T1 test and significant stenosis on coronary arteriography was significantly associated with cardiac events during the follow-up period.
Several prior studies have reported the prevalence of CAD in patients with symptomatic cerebrovascular disease, each with significant limitations. Hertzer Tl test results, they could still be referred for coronary angiography to exclude severe three-vessel ("balanced") disease. However, the combination of reversible 20l Tl defects and abnormal coronary angiography had prognostic significance in our patients.
The cardiac event rate (7% new angina, 3% atrial fibrillation, no cases of myocardial infarction or cardiac death) was low in our study. The typical annual rate of cardiac death among patients with cerebrovascular disease is 5-6%.
2 -3 The low incidence of cardiac events may be related to the routine use of aspirin and the close follow-up in our patients. The use of aspirin has been shown to reduce mortality and myocardial infarction rates in patients with unstable angina and is probably useful in primary prevention of myocardial infarction in patients who are at high risk for developing significant CAD. 37 After our initial work-up, 17 patients were started on medical therapy for CAD, two who developed angina underwent successful percutaneous transluminal coronary angioplasty, and two underwent coronary artery bypass grafting.
The finding of a significantly higher cardiac event rate (29%) among patients with reversible 2O1 T1 defects and coronary arterial stenosis of >50% compared with the rate among those without abnormal 201 Tl test results (9%) emphasizes the prognostic importance of performing routine screening with 2O1 T1 scintigraphy in patients with both asymptomatic and symptomatic cerebrovascular disease. In this era of intense investigation of new therapeutic interventions for stroke prevention, it is still important to pay attention to the management of coexistent coronary artery disease. Performing 201 Tl scintigraphy (and then coronary arteriography when the 201 Tl test is abnormal) in all patients with cerebrovascular disease, whether or not they are symptomatic and whether or not there is a history of CAD, can identify patients at higher risk for subsequent cardiac events. It is of interest that patients with abnormal 2O1 T1 test results had a higher prevalence of coronary events especially given that treatment was altered based on the abnormal results. Therefore, it is possible that even more patients with abnormal 201 Tl test results might have had coronary events if treatment had not been altered.
